IL208445A0 - Compositions and methods for immunotherapy - Google Patents

Compositions and methods for immunotherapy

Info

Publication number
IL208445A0
IL208445A0 IL208445A IL20844510A IL208445A0 IL 208445 A0 IL208445 A0 IL 208445A0 IL 208445 A IL208445 A IL 208445A IL 20844510 A IL20844510 A IL 20844510A IL 208445 A0 IL208445 A0 IL 208445A0
Authority
IL
Israel
Prior art keywords
immunotherapy
compositions
methods
Prior art date
Application number
IL208445A
Other languages
English (en)
Original Assignee
Cognate 3 Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cognate 3 Llc filed Critical Cognate 3 Llc
Publication of IL208445A0 publication Critical patent/IL208445A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
IL208445A 2008-04-03 2010-10-03 Compositions and methods for immunotherapy IL208445A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4221008P 2008-04-03 2008-04-03
PCT/US2009/002134 WO2009145841A1 (en) 2008-04-03 2009-04-03 Compositions and methods for immunotherapy

Publications (1)

Publication Number Publication Date
IL208445A0 true IL208445A0 (en) 2010-12-30

Family

ID=41267359

Family Applications (1)

Application Number Title Priority Date Filing Date
IL208445A IL208445A0 (en) 2008-04-03 2010-10-03 Compositions and methods for immunotherapy

Country Status (12)

Country Link
US (5) US20090281047A1 (enExample)
EP (1) EP2271350A4 (enExample)
JP (1) JP2011516478A (enExample)
CN (1) CN102046180A (enExample)
AU (1) AU2009251848A1 (enExample)
CA (1) CA2757437A1 (enExample)
IL (1) IL208445A0 (enExample)
MX (1) MX339451B (enExample)
NZ (1) NZ588668A (enExample)
RU (1) RU2010144744A (enExample)
WO (1) WO2009145841A1 (enExample)
ZA (1) ZA201007830B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100160368A1 (en) 2008-08-18 2010-06-24 Gregory Jefferson J Methods of Treating Dermatological Disorders and Inducing Interferon Biosynthesis With Shorter Durations of Imiquimod Therapy
DK2378876T3 (en) 2008-12-19 2019-03-11 Medicis Pharmaceutical Corp IMIQUIMOD FORMULATIONS WITH LOWER DOSAGE STRENGTH AND SHORT-TERM DOSAGE PLAN FOR TREATMENT OF ACTINIC KERATOSIS
AU2010274097B2 (en) 2009-07-13 2016-06-16 Medicis Pharmaceutical Corporation Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts
US20140155344A1 (en) * 2010-06-07 2014-06-05 Neil P. Desai Combination therapy methods for treating proliferative diseases
US20130171279A1 (en) * 2012-01-04 2013-07-04 Physicianrx, Llc Composition for Reducing Side- and After-Effects of Cancer Treatment
CN103156951A (zh) * 2013-04-11 2013-06-19 太仓市胜舟生物技术有限公司 一种治疗b细胞淋巴瘤的组合药物
ES2886019T3 (es) * 2013-12-20 2021-12-16 Campillo Ramiro Moises Vergara Combinación de piridoxina, ácido fólico e iones magnesio para el tratamiento del cáncer
NZ745881A (en) 2016-02-04 2023-04-28 Auransa Inc Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity
EP3493815B1 (en) * 2016-08-03 2022-02-16 Zhuhai Beihai Biotech Co., Ltd. Formulations of fosaprepitant and aprepitant
CA3108483A1 (en) * 2017-08-07 2019-02-14 Cognate 3 Llc Compositions and methods for inducing apoptosis in anaerobic cells and related clinical methods for treating cancer and pathogenic infections
WO2022200833A1 (en) * 2021-03-25 2022-09-29 2B-Shvat Ltd. Benzaldehyde extracted from rosales as foodstuff preservative, animal-feed additive, and for treatment of the covid-19 virus
JP7018531B1 (ja) 2021-04-30 2022-02-10 潤 齋藤 Ａｘｌ阻害剤
IL315231A (en) * 2022-02-24 2024-10-01 Shmuel Robinov Methods of using benzaldehyde preparations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4882314A (en) * 1985-12-02 1989-11-21 Rikagaku Kenkyusho A composition and method of treating selected malignant conditions
US6407071B1 (en) * 1998-06-04 2002-06-18 Co-Enzyme Technology Ltd. Method and composition for treating malignant cells
NO309305B1 (no) * 1999-02-19 2001-01-15 Norsk Hydro As Anvendelse av benzaldehydderivater ved fremstilling av farmasöytiske preparater for forebygging og/eller behandling av kreft, samt visse nye benzaldehydderivater

Also Published As

Publication number Publication date
US20090281047A1 (en) 2009-11-12
CN102046180A (zh) 2011-05-04
NZ588668A (en) 2013-01-25
ZA201007830B (en) 2011-07-27
RU2010144744A (ru) 2012-05-10
US20120251490A1 (en) 2012-10-04
JP2011516478A (ja) 2011-05-26
EP2271350A1 (en) 2011-01-12
CA2757437A1 (en) 2009-12-03
MX339451B (es) 2016-05-27
WO2009145841A1 (en) 2009-12-03
EP2271350A4 (en) 2011-05-18
US20110311478A1 (en) 2011-12-22
AU2009251848A1 (en) 2009-12-03
US20110311477A1 (en) 2011-12-22
US20110311476A1 (en) 2011-12-22
MX2010010866A (es) 2011-02-24

Similar Documents

Publication Publication Date Title
IL208284A0 (en) Compositions and methods for preparing and using same
IL210153A0 (en) Nutrigenomics methods and compositions
SI3812360T1 (sl) Monoklorotrifluoropropenske spojine in sestavki ter postopki, ki jih uporabljajo
IL208445A0 (en) Compositions and methods for immunotherapy
EP2334804A4 (en) COCULTURAL COMPOSITIONS AND METHODS
GB0815872D0 (en) Novel method and compositions
IL212822A0 (en) Anti-cxcr1 compositions and methods
SI2137210T1 (sl) Nov postopek in sestavki
GB0819530D0 (en) Methods and compositions
IL210559A0 (en) Novel compositions and methods
GB0903299D0 (en) Composition and methods
SG10201505149WA (en) Novel compositions and methods
GB0817585D0 (en) Novel compositions and methods
IL205248A0 (en) Compositions and methods for making androstenediones
EP2498750A4 (en) COMPOSITIONS AND METHODS FOR REINFORCING THE EYES
EP2294198A4 (en) METHODS AND COMPOSITIONS FOR ENHANCING PLANTS
GB0901494D0 (en) Compositions and Methods
GB0811250D0 (en) Methods and compositions
EP2488624A4 (en) STABILIZED SURFACTANT-OXIDANT COMPOSITIONS AND METHODS THEREOF
GB0816534D0 (en) Compositions and methods
GB0811152D0 (en) Methods and compositions
GB0803464D0 (en) Methods and compositions
GB0818399D0 (en) Methods and compositions
GB0802079D0 (en) Method and compositions
GB0909720D0 (en) Compositions and methods